Are Suraksha Diagno. latest results good or bad?
Suraksha Diagnostic's latest results show strong sales and operating profit growth, with net sales reaching Rs 72.59 crore and operating profit at Rs 23.75 crore. However, rising interest costs have raised concerns about financial stability, as they increased by 31.07%, impacting the company's ability to manage interest payments effectively.
Suraksha Diagnostic has reported its financial results for the quarter ending June 2025, showcasing a mix of operational trends. The company achieved its highest quarterly net sales in the last five quarters, amounting to Rs 72.59 crore, reflecting a quarter-on-quarter growth of 9.56%. The operating profit also reached a peak of Rs 23.75 crore, indicating a favorable near-term trend in revenue generation.However, the company faced challenges with rising interest costs, which increased by 31.07% quarter on quarter to Rs 2.70 crore, the highest in the last five quarters. This rise in interest expenses has led to a decline in the operating profit to interest ratio, now at its lowest level of 8.80 times in the last five quarters, suggesting a reduced ability to manage interest payments effectively.
Additionally, the profit before tax (PBT) grew by 23.1% compared to the average of the previous four quarters, amounting to Rs 11.56 crore. Despite these positive indicators, the company saw an adjustment in its evaluation over the past three months.
In summary, while Suraksha Diagnostic has recorded strong sales and operating profit figures, the rising interest costs present challenges that may impact its financial stability moving forward.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
